Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030

被引:1
|
作者
V. Kim, Thanh [1 ,2 ]
Pham, Trang N. D. [3 ,4 ]
Le, Duc H. [1 ]
Dao, Diem V. B. [4 ]
Phan, Loc T. B. [4 ]
Le, Anh [4 ]
Trang, Amy [4 ]
Tang, Hong K. [1 ]
Liu, Jason J. [2 ,5 ,7 ]
Dao, Doan Y. [4 ,6 ,8 ]
机构
[1] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
[2] Natl Yang Ming Chiao Tung Univ, Coll Med, Int Hlth Program, Taipei, Taiwan
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[4] Vietnam Viral Hepatitis Alliance, Reston, VA USA
[5] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan
[6] Johns Hopkins Univ, Ctr Excellence Liver Dis Viet Nam, Sch Med, Baltimore, MD USA
[7] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Med Bldg II,155,Sect 2,Linong St, Taipei, Taiwan
[8] Johns Hopkins Univ, Sch Med, Ross Res Bldg,Room 310,720 Rutland Ave, Baltimore, MD 21205 USA
关键词
Hepatitis B virus; Vaccination; Elimination; Survey; Adult; Viet Nam; Lower-middle-income country; INFECTION; VIRUS;
D O I
10.1016/j.vaccine.2022.12.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Gaps in adult hepatitis B vaccination were undefined in Vietnam, a lower-middle-income country. To address these gaps, this study defined hepatitis B vaccine coverage in adults and its associated factors in Ho Chi Minh City (HCMC), Viet Nam. We also proposed interventional strategies, prioritizing gap identification to facilitate hepatitis B elimination by 2030 and beyond.Method: During 2019-2020, a multi-stage cluster serosurvey with probability proportional to size was conducted to representatively invite 20,000 adults (18 years or older) throughout HCMC for hepatitis B screening (HBsAg, anti-HBs, and anti-HBc). Serologic results defined two dependent variables: vaccine -induced immunity (i.e., isolated anti-HBs) and susceptibility (i.e., HBV naive). Associations of dependent variables with surveyed demographics, socioeconomic statuses, behaviors, and medical history at risk for hepatitis B were evaluated using weighted Poisson regression.Results: The prevalence was 18.5% (95%CI, 17.3-20.0%) for vaccine-induced immunity and 37.7% (35.6-39.8%) for susceptibility. Even though analyses in the general population revealed a falling trend in vaccine-induced immunity prevalence from younger to older age groups, sensitivity analyses in the non-infected population (i.e., those who were both negative for HBsAg and anti-HBc) showed that younger age groups, especially those aged 30 to 50 years, had the lowest prevalence. Social inequalities existed in different ethnicities, residence areas, education levels, house ownership, and health insurance statuses. There was no significant association between vaccine-induced immunity or susceptibility and risky behaviors and medical histories.Conclusion: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页码:976 / 988
页数:13
相关论文
共 50 条
  • [1] Toward elimination and eradication of hepatitis B
    Chen, Ding-Shinn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (01) : 19 - 25
  • [2] Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030
    Al-Busafi, Said A.
    Alwassief, Ahmed
    VACCINES, 2024, 12 (03)
  • [3] Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination
    Al Awaidy, Salah Thabit
    Bawikar, Shyam Pandurang
    Al Busaidy, Suleiman Salim
    Al Mahrouqi, Salim
    Al Baqlani, Said
    Al Obaidani, Idris
    Alexander, James
    Patel, Minal K.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (04) : 811 - 815
  • [4] Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
    Chen, Ding-Shinn
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 805 - 816
  • [5] Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection
    Li, Xi
    Wiesen, Eric
    Diorditsa, Sergey
    Toda, Kohei
    Thi Hong Duong
    Lien Huong Nguyen
    Van Cuong Nguyen
    Tran Hien Nguyen
    VACCINE, 2016, 34 (06) : 869 - 873
  • [6] World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal
    Diarra, Birama
    Yonli, Albert Theophane
    Ouattara, Abdoul Karim
    Zohoncon, Theodora Mahoukede
    Traore, Lassina
    Nadembega, Christelle
    Obiri-Yeboah, Dorcas
    Yara, Justine
    Pietra, Virginio
    Ouedraogo, Paul
    Bougouma, Alain
    Sanogo, Rokia
    Simpore, Jacques
    VIROLOGY JOURNAL, 2018, 15
  • [7] World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal
    Birama Diarra
    Albert Theophane Yonli
    Abdoul Karim Ouattara
    Theodora Mahoukèdè Zohoncon
    Lassina Traore
    Christelle Nadembega
    Dorcas Obiri-Yeboah
    Justine Yara
    Virginio Pietra
    Paul Ouedraogo
    Alain Bougouma
    Rokia Sanogo
    Jacques Simpore
    Virology Journal, 15
  • [8] Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
    Kim, Sun Woong
    Yoon, Jun Sik
    Lee, Minjong
    Cho, Yuri
    CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (01) : 17 - 30
  • [9] Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive
    Dore, Gregory J.
    Cowie, Benjamin
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : 753 - 754
  • [10] Hepatitis B vaccination status among healthy adults in Germany
    Ringwald, Juergen
    Mertz, Iris
    Zimmermann, Robert
    Weisbach, Volker
    Rabe, Christina
    Strasser, Erwin
    Seyboth, Susanne
    Eckstein, Reinhold
    HEALTH POLICY, 2006, 79 (2-3) : 306 - 312